HCG — Healthcare Global Enterprises Income Statement
0.000.00%
- IN₹48.60bn
- IN₹58.64bn
- IN₹19.08bn
- 52
- 13
- 42
- 24
Annual income statement for Healthcare Global Enterprises, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 10,923 | 10,092 | 13,948 | 16,914 | 19,079 |
Cost of Revenue | |||||
Gross Profit | 6,026 | 5,431 | 7,401 | 9,112 | 10,189 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 10,719 | 11,395 | 12,228 | 15,575 | 17,530 |
Operating Profit | 204 | -1,303 | 1,719 | 1,339 | 1,549 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1,193 | -2,287 | 878 | 449 | 677 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1,255 | -2,211 | 389 | 176 | 413 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -1,067 | -1,935 | 537 | 293 | 481 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1,067 | -1,935 | 537 | 293 | 481 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -12.1 | -11.7 | -0.543 | 2.14 | 3.26 |